Table 3.
Relationships between FEPM and clinicopathological features of HCC patients.
| Characteristics | TCGA | ICGC | ||||
|---|---|---|---|---|---|---|
| Low-FEPM | High-FEPM | P value | Low-FEPM | High-FEPM | P value | |
| Total case | 183 | 182 | 116 | 115 | ||
| Age(%) | 0.270 | 0.654 | ||||
| ≤60 | 92(50.3) | 81(44.5) | 26(22.4) | 23(20.0) | ||
| >60 | 91(49.7) | 101(55.5) | 90(77.6) | 92(80.0) | ||
| Gender(%) | 0.710 | 0.315 | ||||
| Male | 125(68.3) | 121(66.5) | 82(70.7) | 88(76.5) | ||
| Female | 58(31.7) | 61(33.5) | 34(29.3) | 27(23.5) | ||
| Tumor grade(%) | <0.001 | – | ||||
| G1-G2 | 133(73.9) | 97(53.9) | – | – | ||
| G3-G4 | 47(26.1) | 83(46.1) | – | – | ||
| AFP | 0.003 | |||||
| ≤400 | 123(84.2) | 90(69.2) | – | – | ||
| >400 | 23(15.8) | 40(30.8) | – | – | ||
| Vascular invasion(%) | 0.001 | – | ||||
| No | 123(74.5) | 82(56.2) | – | – | ||
| Yes | 42(25.5) | 64(43.8) | – | – | ||
| TNM stage(%) | 0.001 | 0.006 | ||||
| I-II | 144(82.3) | 110(66.3) | 81(69.8) | 60(52.2) | ||
| III-IV | 31(17.7) | 56(33.7) | 35(30.2) | 55(47.8) | ||
| Child-Pugh(%) | 0.764 | – | ||||
| A | 125(91.2) | 91(90.1) | – | – | ||
| B-C | 12(8.8) | 10(9.9) | – | – | ||
| Fibrosis(%) | 0.317 | – | ||||
| No | 48(38.1) | 26(31.3) | – | – | ||
| Yes | 78(61.9) | 57(68.7) | – | – | ||